Back
Speaker illustration

Doctor Nitasha Sarswat

University of Chicago Medical Center, Chicago (United States of America)

Member of:

European Society of Cardiology

Presentations Articles

Acoramidis-mediated improvement in NT-proBNP at month 30 compared with placebo in patients with ATTR-CM: results from the ATTRibute-CM study

Event: ESC Congress 2025

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis

Access
Like
Thumbnail

Panel discussion and audience Q&A

Event: ESC Congress 2025

Topic: Cardiac Amyloidosis

Session: A new chapter in transthyretin amyloid cardiomyopathy (ATTR-CM): what comes next in clinical practice?

Access
Like
Thumbnail

From evidence to action: translating data into clinical practice

Event: ESC Congress 2025

Topic: Cardiac Amyloidosis

Session: A new chapter in transthyretin amyloid cardiomyopathy (ATTR-CM): what comes next in clinical practice?

Access
Like
Thumbnail

TTR stabilisation for the management of variant and Wild-Type ATTR-CM

Event: ESC Congress 2025

Topic: Cardiac Amyloidosis

Session: The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources